Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Endocrinological Investigation
Published in: Journal of Endocrinological Investigation 9/2019

01-09-2019 | Polycystic Ovary Syndrome | Original Article

The resting metabolic rate in women with polycystic ovary syndrome and its relation to the hormonal milieu, insulin metabolism, and body fat distribution: a cohort study

Authors: D. Romualdi, V. Versace, V. Tagliaferri, S. De Cicco, V. Immediata, R. Apa, M. Guido, A. Lanzone

Published in: Journal of Endocrinological Investigation | Issue 9/2019

Login to get access

Abstract

Purpose

To evaluate possible alterations of a major determinant of energy expenditure, the resting metabolic rate (RMR), in women with polycystic ovary syndrome (PCOS) compared with age-BMI similar controls. To assess whether the hormonal milieu, the body fat distribution and the insulin metabolism may affect energy consumption in these patients.

Methods

This is a monocentric observational prospective cohort study, including 109 Caucasian PCOS subjects and 31 healthy control women. (Median age PCOS 26.0 ± 9.2 years, controls 25.5 ± 8.5 years; median BMI-body mass index PCOS 26.4 ± 9.4 kg/m2, controls 27.2 ± 12.8 kg/m2). RMR was evaluated by the SenseWear Armband (SWA), a reliable and validated metabolic holter, never previously used in the PCOS population to this purpose. Hormonal assessment, insulin metabolism evaluated by HOMA-IR and OGTT, anthropometric features (BMI and WHR) were also assessed.

Results

Median RMR resulted similar in PCOS and control women: 1520.0 ± 248.00 kcal/day vs 1464.0 ± 332.70 kcal/day (p = 0.472), even after adjusting for BMI, fat distribution, insulin metabolism parameters. RMR resulted significantly correlated with BMI, WHR, estradiol levels, SHBG, total cholesterol, triglycerides, basal glycaemia, basal insulinemia, AUC insulin 240’, and HOMA. In the subgroup of patients with WHR > 0.85, PCOS women showed a significantly lower RMR compared with controls.

Conclusions

The higher prevalence of obesity, which negatively influences the reproductive and general health of PCOS women, could be related to factors other than an intrinsic alteration of the RMR. Further studies are needed to clarify the possible role of the visceral fat in modulating the energy balance in PCOS.

Trial registration number

clinicaltrials.gov Identifier NCT03132545.
Literature
1.
Pasquali R, Gambineri A (2018) New perspectives on the definition and management of polycystic ovary syndrome. J Endocrinol Invest 41(10):1123–1135CrossRefPubMed
2.
Rocca ML, Venturella R, Mocciaro R, Di Cello A, Sacchinelli A, Russo V, Trapasso S, Zullo F, Morelli M (2015) Polycystic ovary syndrome: chemical pharmacotherapy. Expert Opin Pharmacother 16:1369–1393CrossRefPubMed
3.
4.
Falbo A, Orio F, Venturella R, Rania E, Materazzo C, Tolino A, Zullo F, Palomba S (2009) Does metformin affect ovarian morphology in patients with polycystic ovary syndrome? A retrospective cross-sectional preliminary analysis. J Ovarian Res 31(2):5CrossRef
5.
Genazzani AD, Shefer K, Della Casa D, Prati A, Napolitano A, Manzo A, Despini G, Simoncini T (2018) Modulatory effects of alpha-lipoic acid (ALA) administration on insulin sensitivity in obese PCOS patients. J Endocrinol Invest 41(5):583–590CrossRefPubMed
6.
Daniela R, Valentina I, Simona C, Valeria T, Antonio L (2018) Neuroendocrine regulation of food intake in polycystic ovary syndrome. Reprod Sci. 25(5):644–653 (Epub 2017 Sep 6) CrossRef
7.
Wright CE, Zborowski JV, Talbott EO, McHugh-Pemu K, Youk A (2004) Dietary intake, physical activity, and obesity in women with polycystic ovary syndrome. Int J Obes Relat Metab Disord 28:1026–1032CrossRefPubMed
8.
Ewens KG 1st, Jones MR, Ankener W, Stewart DR, Urbanek M, Dunaif A, Legro RS, Chua A, Azziz R, Spielman RS et al (2011) FTO and MC4R gene variants are associated with obesity in polycystic ovary syndrome. PLoS One 6:e16390CrossRefPubMedPubMedCentral
9.
Larsson I, Hulthén L, Landén M, Pålsson E, Janson P, Stener-Victorin E (2016) Dietary intake, resting energy expenditure, and eating behavior in women with and without polycystic ovary syndrome. Clin Nutr 35:213–218CrossRefPubMed
10.
Douglas CC, Norris LE, Oster RA, Darnell BE, Azziz R, Gower BA (2006) Difference in dietary intake between women with polycystic ovary syndrome and healthy controls. Fertil Steril 86:411–417CrossRefPubMed
11.
Behboudi-Gandevani S, Ramezani Tehrani F, Bidhendi Yarandi R, Noroozzadeh M, Hedayati M, Azizi F (2017) The association between polycystic ovary syndrome, obesity, and the serum concentration of adipokines. J Endocrinol Invest 40(8):859–866CrossRefPubMed
12.
Blaxter K (1989) Energy metabolism in animals and man. Cambridge University Press, Cambridge
13.
Buscemi S, Verga S, Caimi G, Cerasola G (2007) A low resting metabolic rate is associated with metabolic syndrome. Clin Nutr 26:806–809 (Epub 2007 Oct 23)CrossRefPubMed
14.
Buscemi S, Donatelli M, Grosso G, Vasto S, Galvano F, Costa F, Rosafio G, Verga S (2014) Resting energy expenditure in type 2 diabetic patients and the effect of insulin bolus. Diabetes Res Clin Pract 106:605–610 (Epub 2014 Oct 2) CrossRefPubMed
15.
16.
Schoeller DA (1999) Recent advances in nutritional sciences recent advances from application of doubly labeled water to measurement of human energy. J Nutr 129:1765–1768CrossRefPubMed
17.
Cosar E, Köken G, Sahin FK, Akgün L, Uçok K, Genç A, Yilmazer M (2008) Resting metabolic rate and exercise capacity in women with polycystic ovary syndrome. Int J Gynaecol Obstet 101:31–34 (Epub 2008 Feb 20) CrossRefPubMed
18.
Georgopoulos NA, Saltamavros AD, Vervita V, Karkoulias K, Adonakis G, Decavalas G, Kourounis G, Markou KB, Kyriazopoulou V (2009) Basal metabolic rate is decreased in women with polycystic ovary syndrome and biochemical hyperandrogenemia and is associated with insulin resistance. Fertil Steril 92:250–255 (Epub 2008 Aug 3) CrossRefPubMed
19.
Fruin ML, Rankin JW (2004) Validity of a multi-sensor armband in estimating rest and exercise energy expenditure. Med Sci Sports Exerc 36:1063–1069CrossRefPubMed
20.
Liden CB, Wolowicz M, Stivoric J, Teller A, Vishnubhatla S, Pelletier R, Farringdon J (2002) Accuracy and reliability of the sensewear armband as an energy expenditure assessment device. BodyMedia Inc., Pittsburgh
21.
Farooqi N, Slinde F, Håglin L, Sandström T (2013) Validation of sensewear armband and actiheart monitors for assessments of daily energy expenditure in free-living women with chronic obstructive pulmonary disease. Physiol Rep 1:e00150CrossRefPubMedPubMedCentral
22.
Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81:19–25
23.
24.
New MI, Lorenzen F, Lerner AJ, Kohn B, Oberfield SE, Pollack MS, Dupont B, Stoner E, Levy DJ, Pang S et al (1983) Genotyping steroid 21-hydroxylase deficiency: hormonal reference data. J Clin Endocrinol Metab 57:320–326CrossRefPubMed
25.
Treloar AE, Boynton RE, Behn BG, Brown BW (1967) Variation of the human menstrual cycle through reproductive life. Int J Fertil 12:77–126PubMed
26.
Peterkin BB (1990) Dietary guidelines for Americans. J Am Diet Assoc 90:1725–1727PubMed
27.
Orsini LF, Venturoli S, Lorusso R, Pluchinotta V, Paradisi R, Bovicelli L (1985) Ultrasonic findings in polycystic ovarian disease. Fertil Steril 43:709–714CrossRefPubMed
28.
Ciampelli M, Leoni F, Cucinelli F, Mancuso S, Panunzi S, De Gaetano A, Lanzone A (2005) Assessment of insulin sensitivity from measurements in the fasting state and during an oral glucose tolerance test in polycystic ovary syndrome and menopausal patients. J Clin Endocrinol Metab 90:1398–1406CrossRefPubMed
29.
Ziaee A, Esmailzadehha N, Oveisi S, Ghorbani A, Ghanei L (2015) The threshold value of homeostasis model assessment for insulin resistance in Qazvin Metabolic Diseases Study (QMDS): assessment of metabolic syndrome. J Res Health Sci 15:94–100PubMed
30.
31.
Santos-Lozano A, Hernández-Vicente A, Pérez-Isaac R (2017) Is the SenseWear Armband accurate enough to quantify and estimate energy expenditure in healthy adults? Ann Transl Med 5:97CrossRefPubMedPubMedCentral
32.
Faloia E, Canibus P, Gatti C, Frezza F, Santangelo M, Garrapa GG, Boscaro M (2004) Body composition, fat distribution and metabolic characteristics in lean and obese women with polycystic ovary syndrome. J Endocrinol Invest 27:424–429CrossRefPubMed
33.
Segal KR, Dunaif A (1990) Resting metabolic rate and postprandial thermogenesis in polycystic ovarian syndrome. Int J Obes 14:559–567PubMed
34.
Ravussin E, Lillioja S, Knowler WC, Christin L, Freymond D, Abbott WG, Boyce V, Howard BV, Bogardus C (1988) Reduced rate of energy expenditure as a risk factor for body-weight gain. N Engl J Med 25(318):467–472CrossRef
35.
DeLany JP, Kelley DE, Hames KC, Jakicic JM, Goodpaster BH (2013) High energy expenditure masks low physical activity in obesity. Int J Obes (Lond) 37:1006–1011CrossRef
36.
Lührmann PM, Herbert BM, Neuhäuser-Berthold M (2001) Effects of fat mass and body fat distribution on resting metabolic rate in the elderly. Metabolism 50:972–975CrossRefPubMed
37.
Arner P (1995) Differences in lipolysis between human subcutaneous and omental adipose tissues. Ann Med 27:435–438CrossRefPubMed
38.
de Luis DA, Aller R, Izaola O, Gonzalez Sagrado M, Conde R (2005) Resting energy expenditure, cardiovascular risk factors and insulin resistance in obese patients. Ann Nutr Metab 49:381–385CrossRefPubMed
39.
Braun B, Zimmermann MB, Kretchmer N (1996) Relationships between glucose metabolism and thermogenesis with and without prior exercise in obese women with noninsulin-dependent diabetes mellitus. Metabolism 45:747–752CrossRefPubMed
Metadata
Title
The resting metabolic rate in women with polycystic ovary syndrome and its relation to the hormonal milieu, insulin metabolism, and body fat distribution: a cohort study
Authors
D. Romualdi
V. Versace
V. Tagliaferri
S. De Cicco
V. Immediata
R. Apa
M. Guido
A. Lanzone
Publication date
01-09-2019
Publisher
Springer International Publishing
Published in
Journal of Endocrinological Investigation / Issue 9/2019
Electronic ISSN: 1720-8386
DOI
https://doi.org/10.1007/s40618-019-01029-2

Other articles of this Issue 9/2019

Journal of Endocrinological Investigation 9/2019 Go to the issue

Original Article

Increased aortic stiffness index in patients with type 1 diabetes without cardiovascular disease compared to controls

Short Review

Functional hypothalamic and drug-induced amenorrhea: an overview

Endocrinology and Art

The representation of a goiter by Renaissance painter Moretto da Brescia

Original Article

First-year predictors of health-related quality of life changes in short-statured children treated with human growth hormone

Original Article

Vitamin D status and non-alcoholic fatty liver disease in patients with type 1 diabetes

Original Article

Comparative assessment of hypothalamic-pituitary-adrenal axis suppression secondary to intrabursal injection of different glucocorticoids: a pilot study
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits